Stanniocalcin-1 is a glycoprotein, a homologue of a hormone stanniocalcin, first discovered in bony fishes. In humans it is encoded by the STC1gene.[1][2]
Function
This gene encodes a secreted, homodimeric glycoprotein that is expressed in a wide variety of tissues and may have autocrine or paracrine functions. Human Stanniocalcin-1 is a putative molecular biomarker of leukemic microenvironment and the only molecular function known up to date is a SUMO E3 ligase activity in the SUMOylation cycle. STC1 interacts with lots of proteins in the cytoplasm, mitochondria, endoplasmatic reticulum and dot-like fashion in the nucleus. The N-terminal region of STC1 is the function region which is responsible to establish the interaction with its partners, including SUMO1.[3] Low resolution studies shows that STC1 is an anti-parallel homodimer in solution and the cystein 202 is responsible for the dimerization of this protein. All the 5 dissulfide bonds of human STC1 are conserved and has the same profile of fish STC.[4] The gene contains a 5' UTR rich in CAG trinucleotide repeats. The encoded protein contains 11 conserved cysteine residues and is phosphorylated by protein kinase C exclusively on its serine residues. The protein may play a role in the regulation of renal and intestinal calcium and phosphate transport, cell metabolism, or cellular calcium/phosphate homeostasis. Overexpression of human stanniocalcin 1 in mice produces high serum phosphate levels, dwarfism, and increased metabolic rate. This gene has altered expression in hepatocellular, ovarian, and breast cancers.[2]
References
↑Chang AC, Jeffrey KJ, Tokutake Y, Shimamoto A, Neumann AA, Dunham MA, Cha J, Sugawara M, Furuichi Y, Reddel RR (Feb 1998). "Human stanniocalcin (STC): genomic structure, chromosomal localization, and the presence of CAG trinucleotide repeats". Genomics. 47 (3): 393–8. doi:10.1006/geno.1997.5120. PMID9480753.
Chang AC, Jellinek DA, Reddel RR (Sep 2003). "Mammalian stanniocalcins and cancer". Endocrine-Related Cancer. 10 (3): 359–73. doi:10.1677/erc.0.0100359. PMID14503913.
Liang P, Averboukh L, Keyomarsi K, Sager R, Pardee AB (Dec 1992). "Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells". Cancer Research. 52 (24): 6966–8. PMID1458489.
Chang AC, Janosi J, Hulsbeek M, de Jong D, Jeffrey KJ, Noble JR, Reddel RR (Aug 1995). "A novel human cDNA highly homologous to the fish hormone stanniocalcin". Molecular and Cellular Endocrinology. 112 (2): 241–7. doi:10.1016/0303-7207(95)03601-3. PMID7489828.
Varghese R, Gagliardi AD, Bialek PE, Yee SP, Wagner GF, Dimattia GE (Mar 2002). "Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice". Endocrinology. 143 (3): 868–76. doi:10.1210/en.143.3.868. PMID11861508.
McCudden CR, James KA, Hasilo C, Wagner GF (Nov 2002). "Characterization of mammalian stanniocalcin receptors. Mitochondrial targeting of ligand and receptor for regulation of cellular metabolism". The Journal of Biological Chemistry. 277 (47): 45249–58. doi:10.1074/jbc.M205954200. PMID12223480.
Serlachius M, Alitalo R, Olsen HS, Andersson LC (Nov 2002). "Expression of stanniocalcin-1 in megakaryocytes and platelets". British Journal of Haematology. 119 (2): 359–63. doi:10.1046/j.1365-2141.2002.03916.x. PMID12406069.
Sheikh-Hamad D, Bick R, Wu GY, Christensen BM, Razeghi P, Poindexter B, Taegtmeyer H, Wamsley A, Padda R, Entman M, Nielsen S, Youker K (Jul 2003). "Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure". American Journal of Physiology. Heart and Circulatory Physiology. 285 (1): H442–8. doi:10.1152/ajpheart.01071.2002. PMID12663264.
Zlot C, Ingle G, Hongo J, Yang S, Sheng Z, Schwall R, Paoni N, Wang F, Peale FV, Gerritsen ME (Nov 2003). "Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor". The Journal of Biological Chemistry. 278 (48): 47654–9. doi:10.1074/jbc.M301353200. PMID14500721.
McCudden CR, Majewski A, Chakrabarti S, Wagner GF (Jan 2004). "Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas". Molecular and Cellular Endocrinology. 213 (2): 167–72. doi:10.1016/j.mce.2003.10.042. PMID15062564.
Luo CW, Kawamura K, Klein C, Hsueh AJ (Aug 2004). "Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors". Molecular Endocrinology. 18 (8): 2085–96. doi:10.1210/me.2004-0066. PMID15131261.
Serlachius M, Andersson LC (Jun 2004). "Upregulated expression of stanniocalcin-1 during adipogenesis". Experimental Cell Research. 296 (2): 256–64. doi:10.1016/j.yexcr.2004.02.016. PMID15149855.